Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$2.65B |
| 2 |
TSMC
TSM
|
+$1.25B |
| 3 |
Microsoft
MSFT
|
+$1.1B |
| 4 |
Micron Technology
MU
|
+$957M |
| 5 |
UnitedHealth
UNH
|
+$774M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan International Research Enhanced Equity ETF
JIRE
|
+$785M |
| 2 |
Broadcom
AVGO
|
+$635M |
| 3 |
Netflix
NFLX
|
+$580M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 5 |
KraneShares CSI China Internet ETF
KWEB
|
+$267M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.02% |
| 2 | Consumer Discretionary | 0.76% |
| 3 | Healthcare | 0.56% |
| 4 | Financials | 0.54% |
| 5 | Communication Services | 0.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
12851
Aterian
ATER
$7.46M
| $21.2K | ﹤0.01% |
36,991
-8,061
| -18% | -$5.27K |
|
|
CMMB
12852
Chemomab Therapeutics
CMMB
$19M
| $21.2K | ﹤0.01% |
+13,491
| New | +$23K |
|
|
UCL
12853
uCloudlink Group
UCL
$14.9M
| $20.9K | ﹤0.01% |
14,799
+1,271
| +9% | +$2.04K |
|
12854
Brilliant Earth
BRLT
$21.6M
| $20.6K | ﹤0.01% |
15,485
-15,707
| -50% | -$23.7K |
|
|
HQWWW
12855
Horizon Quantum Holdings Warrant
HQWWW
$55.5M
| $20.6K | ﹤0.01% |
+10,026
| New | +$23.9K |
|
12856
CALL
Zevia
ZVIA
$101M
| $20.4K | ﹤0.01% |
17,400
-30,500
| -64% | -$48.4K |
|
12857
Tiziana Life Sciences
TLSA
$139M
| $20.2K | ﹤0.01% |
17,267
+4,178
| +32% | +$5.91K |
|
12858
CALL
FingerMotion
FNGR
$9.91M
| $20.1K | ﹤0.01% |
20,100
-382,100
| -95% | -$456K |
|
|
BULG
12859
Leverage Shares 2X Long BULL Daily ETF
BULG
$7.6M
| $20K | ﹤0.01% |
961
-928
| -49% | -$40.4K |
|
|
FSP
12860
Franklin Street Properties
FSP
$43.4M
| $20K | ﹤0.01% |
30,060
+15,638
| +108% | +$12.1K |
|
|
AIFU
12861
AIFU Inc
AIFU
$138M
| $19.9K | ﹤0.01% |
714
-524
| -42% | -$21.3K |
|
|
SMCL
12862
CALL
GraniteShares 2x Long SMCI Daily ETF
SMCL
$50.2M
| $19.8K | ﹤0.01% |
+1,725
| New | +$49.9K |
|
12863
CALL
INmune Bio
INMB
$67.7M
| $19.8K | ﹤0.01% |
17,500
-21,400
| -55% | -$30.5K |
|
12864
ProQR Therapeutics
PRQR
$332M
| $19.8K | ﹤0.01% |
+12,206
| New | +$20K |
|
12865
PUT
Grove Collaborative
GROV
$41.6M
| $19.3K | ﹤0.01% |
+15,100
| New | +$20.6K |
|
12866
PUT
Talphera
TLPH
$65.4M
| $19.1K | ﹤0.01% |
25,400
-184,100
| -88% | -$167K |
|
12867
Snail Inc
SNAL
$26.5M
| $19K | ﹤0.01% |
7,421
-3,223
| -30% | -$10.9K |
|
12868
CALL
Lufax Holding
LU
$1.13B
| $18.9K | ﹤0.01% |
+10,100
| New | +$25.5K |
|
|
NNDM
12869
PUT
Nano Dimension
NNDM
$335M
| $18.9K | ﹤0.01% |
11,100
-55,500
| -83% | -$101K |
|
12870
Roadzen
RDZN
$125M
| $18.9K | ﹤0.01% |
+15,714
| New | +$24K |
|
|
LITS
12871
Lite Strategy Inc
LITS
$33.8M
| $18.7K | ﹤0.01% |
16,134
-65,068
| -80% | -$79.2K |
|
|
RVPH
12872
PUT
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
| $18.6K | ﹤0.01% |
25,500
+7,045
| +38% | +$32.1K |
|
|
VCICW
12873
DELISTED
Vine Hill Capital Investment Corp Warrant
VCICW
| $18.5K | ﹤0.01% |
+15,172
| New | +$23.1K |
|
12874
Bridgeline Digital
BLIN
$12.3M
| $18.4K | ﹤0.01% |
23,049
-8,067
| -26% | -$6.8K |
|
|
AACG
12875
ATA Creativity
AACG
$41.9M
| $17.9K | ﹤0.01% |
20,582
-2,279
| -10% | -$2.21K |
|
Similar funds
Jeff Yass's Q1 2026 Portfolio in Review
As of Q1 2026, Jeff Yass held 14,567 positions worth $893B, up 2.9% from $868B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass deployed $70.6B of net new capital in Q1 2026, opening 2,388 new positions and adding to 5,757 existing holdings. Its largest new stake was Sunbelt Rentals Holdings: 830,625 shares worth $54.1M.
By sector, the portfolio is most concentrated in Technology at 2% of assets, up from 1.7% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was JPMorgan International Research Enhanced Equity ETF, an estimated $785M trimmed.
- Jeff Yass's largest Q1 2026 buy was Sunbelt Rentals Holdings: 830,625 shares worth $54.1M.
- Jeff Yass added most to Invesco QQQ Trust in Q1 2026, an estimated $2.65B increase.
- Jeff Yass's biggest Q1 2026 reduction was JPMorgan International Research Enhanced Equity ETF, cutting an estimated $785M.
- Jeff Yass fully exited Schwab International Equity ETF in Q1 2026, selling an estimated $147M.
- Jeff Yass's ten largest holdings make up 27% of its $893B portfolio in Q1 2026.
- Jeff Yass opened 2,388 new positions and closed 1,500 in Q1 2026.
- Jeff Yass's portfolio value rose 2.9% quarter-over-quarter to $893B.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.